U. Kefeli Et Al. , "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience.," Oncology letters , vol.6, pp.605-611, 2013
Kefeli, U. Et Al. 2013. Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience.. Oncology letters , vol.6 , 605-611.
Kefeli, U., Benekli, M., Sevinc, A., Yildiz, R., Kaplan, M., Ciltas, A., ... Balakan, O.(2013). Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience.. Oncology letters , vol.6, 605-611.
Kefeli, UMUT Et Al. "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience.," Oncology letters , vol.6, 605-611, 2013
Kefeli, UMUT Et Al. "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience.." Oncology letters , vol.6, pp.605-611, 2013
Kefeli, U. Et Al. (2013) . "Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience.." Oncology letters , vol.6, pp.605-611.
@article{article, author={UMUT KEFELİ Et Al. }, title={Efficacy of sorafenib in patients with gastrointestinal stromal tumors in the third- or fourth-line treatment: A retrospective multicenter experience.}, journal={Oncology letters}, year=2013, pages={605-611} }